4.5 Review

European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality?

期刊

JOURNAL OF HYPERTENSION
卷 28, 期 4, 页码 637-643

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/HJH.0b013e32833778e1

关键词

blood pressure; hypertension; lifestyle intervention; obesity; weight reduction

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

Norm R. C. Campbell, Paul K. Whelton, Marcelo Orias, Richard D. Wainford, Francesco P. Cappuccio, Nicole Ide, Bruce Neal, Jennifer Cohn, Laura K. Cobb, Jacqui Webster, Kathy Trieu, Feng J. He, Rachael M. McLean, Adriana Blanco-Metzler, Mark Woodward, Nadia Khan, Yoshihiro Kokubo, Leo Nederveen, JoAnne Arcand, Graham A. MacGregor, Mayowa O. Owolabi, Liu Lisheng, Gianfranco Parati, Daniel T. Lackland, Fadi J. Charchar, Bryan Williams, Maciej Tomaszewski, Cesar A. Romero, Beatriz Champagne, Mary R. L'Abbe, Michael A. Weber, Markus P. Schlaich, Agnes Fogo, Valery L. Feigin, Rufus Akinyemi, Felipe Inserra, Bindu Menon, Marcia Simas, Mario Fritsch Neves, Krassimira Hristova, Carolyn Pullen, Sanjay Pandeya, Junbo Ge, Jorge E. Jalil, Ji-Guang Wang, Jiri Wideimsky, Reinhold Kreutz, Ulrich Wenzel, Michael Stowasser, Manuel Arango, Athanasios Protogerou, Eugenia Gkaliagkousi, Flavio Danni Fuchs, Mansi Patil, Andy Wai-Kwong Chan, Janos Nemcsik, Ross T. Tsuyuki, Sanjeevi Nathamuni Narasingan, Nizal Sarrafzadegan, Maria Eugenia Ramos, Natalie Yeo, Hiromi Rakugi, Agustin J. Ramirez, Guillermo Alvarez, Adel Berbari, Cho-il Kim, Sang-Hyun Ihm, Yook-Chin Chia, Tsolmon Unurjargal, Hye Kyung Park, Kolawole Wahab, Helen McGuire, Naranjargal J. Dashdorj, Mohammed Ishaq, Deborah Ignacia D. Ona, Leilani B. Mercado-Asis, Aleksander Prejbisz, Marianne Leenaerts, Carla Simao, Fernando Pinto, Bader Ali Almustafa, Jonas Spaak, Stefan Farsky, Dragan Lovic, Xin-Hua Zhang

JOURNAL OF HUMAN HYPERTENSION (2023)

Review Cardiac & Cardiovascular Systems

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension

Aletta E. Schutte, Tazeen H. Jafar, Neil R. Poulter, Albertino Damasceno, Nadia A. Khan, Peter M. Nilsson, Jafar Alsaid, Dinesh Neupane, Kazuomi Kario, Hind Beheiry, Sofie Brouwers, Dylan Burger, Fadi J. Charchar, Myeong Chan Cho, Tomasz J. Guzik, Ghazi F. Haji Al-Saedi, Muhammad Ishaq, Hiroshi Itoh, Erika S. W. Jones, Taskeen Khan, Yoshihiro Kokubo, Praew Kotruchin, Elizabeth Muxfeldt, Augustine Odili, Mansi Patil, Udaya Ralapanawa, Cesar A. Romero, Markus P. Schlaich, Abdulla Shehab, Ching Siew Mooi, U. Muscha Steckelings, George Stergiou, Rhian M. Touyz, Thomas Unger, Richard D. Wainford, Ji-Guang Wang, Bryan Williams, Brandi M. Wynne, Maciej Tomaszewski

Summary: Hypertension is the leading cause of preventable death globally, but there are significant challenges in its detection, treatment, and control, particularly in low-resource settings. Disparities based on resources, sociodemographic environment, and race contribute to the disproportionate burden of hypertension-related outcomes. Immediate action is needed to address these challenges and reduce inequities in hypertension care.

CARDIOVASCULAR RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry

Roland E. Schmieder, Felix Mahfoud, Giuseppe Mancia, Krzysztof Narkiewicz, Luis Ruilope, David Hutton, Khoa Cao, Douglas A. Hettrick, Martin Fahy, Markus P. Schlaich, Michael Bohm, Jan B. Pietzsch

Summary: Renal denervation using radiofrequency has been found to lower blood pressure and reduce cardiovascular events in patients with uncontrolled hypertension. The magnitude of blood pressure reduction and associated risks of cardiovascular events vary among different high-risk subgroups. Model-based projections suggest that radiofrequency renal denervation provides significant clinical benefits for patients with uncontrolled hypertension.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Clinical Neurology

Effects of wearing textured versus smooth shoe insoles for 12 weeks on gait, foot sensation and patient-reported outcomes, in people with multiple sclerosis: a randomised controlled trial

Anna L. L. Hatton, Katrina Williams, Mark D. D. Chatfield, Sheree Hurn, Jayishni N. N. Maharaj, Elise M. M. Gane, Thomas Cattagni, John Dixon, Keith Rome, Graham Kerr, Sandra G. G. Brauer

Summary: Innovative shoe insoles designed to enhance sensory information on the plantar surface of the feet could improve walking in people with Multiple Sclerosis. However, a study comparing the effects of textured and smooth insoles found no differences in gait, foot sensation, and patient-reported outcomes. Further investigation is needed to explore optimal insole design.

BRAIN IMPAIRMENT (2023)

Article Peripheral Vascular Disease

Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns

Revathy Carnagarin, Janis M. Nolde, Jun Yang, Francine Z. Marques, Dean S. Picone, Gavin W. Lambert, Thomas Beaney, Neil R. Poulter, Aletta E. Schutte, Christopher M. Reid, Derrin Brockman, Markus P. Schlaich

Summary: The awareness, treatment, and control rates of hypertension in Australia are substantially lower than global and high-income country rates, indicating the need for collaborative efforts to improve the situation.

JOURNAL OF HYPERTENSION (2023)

Article Multidisciplinary Sciences

Associations of physical activity levels, and attitudes towards physical activity with blood pressure among adults with high blood pressure in Bangladesh

Fakir M. Amirul Islam, Mohammad Ariful Islam, Mohammad Arzan Hosen, Elisabeth A. Lambert, Ralph Maddison, Gavin W. Lambert, Bruce R. Thompson

Summary: Engaging in high physical activity and having a positive attitude towards physical activity are associated with lower blood pressure levels in rural Bangladesh. Awareness programs should be implemented to promote the benefits of physical activity and increase participation in high physical activity.

PLOS ONE (2023)

Article Peripheral Vascular Disease

Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension

Gianni Sesa-ashton, Janis M. Nolde, Ida Muente, Revathy Carnagarin, Rebecca Lee, Vaughan G. Macefield, Tye Dawood, Yusuke Sata, Elisabeth A. Lambert, Gavin W. Lambert, Antony Walton, Marcio G. Kiuchi, Murray D. Esler, Markus P. Schlaich

Summary: Long-term follow-up studies on catheter-based renal denervation in patients with resistant hypertension show that the method can still effectively reduce blood pressure and decrease medication usage after nearly 9 years of follow-up, without any adverse effects on renal function.

HYPERTENSION (2023)

Review Peripheral Vascular Disease

Multi-organ denervation: a novel approach to combat cardiometabolic disease

Marcio Galindo Kiuchi, Revathy Carnagarin, Vance B. Matthews, Markus P. Schlaich

Summary: Cardiometabolic disorders have a significant impact on quality of life and healthcare systems globally, and the overactivation of the sympathetic nervous system is a key factor in these conditions. Although diet and exercise are traditional methods for combating metabolic disorders, they can be difficult to achieve. Current pharmaceutical approaches have variable effectiveness and may be limited by side effects and non-adherence. Complementary therapies, such as neural modulation, may be beneficial in addressing the burden of cardiometabolic disease.

HYPERTENSION RESEARCH (2023)

Letter Dermatology

Improved methodology in determining melanoma mortality and selecting patients for immunotherapy

A. J. Dixon, H. K. Steinman, A. Kyrgidis, H. Smith, M. Sladden, C. Zouboulis, G. Argenziano, Z. Apalla, A. Lallas, C. Longo, A. Nirenberg, C. Popescu, J. B. Dixon, T. Tzellos, C. Zachary, L. Cleaver, S. Anderson, S. Zagarella, J. M. Thomas

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Surgery

Does a Measure for Weight Regain Provide a Useful Metric?

John B. Dixon

OBESITY SURGERY (2023)

Article Cell Biology

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Aeson Chang, Edoardo Botteri, Ryan D. Gillis, Lukas Lofling, Caroline P. Le, Alexandra I. Ziegler, Ni-Chun Chung, Matthew C. Rowe, Stewart A. Fabb, Brigham J. Hartley, Cameron J. Nowell, Sasagu Kurozumi, Sara Gandini, Elisabetta Munzone, Emilia Montagna, Nina Eikelis, Sarah E. Phillips, Chikako Honda, Kei Masuda, Ayaka Katayama, Tetsunari Oyama, Steve W. Cole, Gavin W. Lambert, Adam K. Walker, Erica K. Sloan

Summary: We found a relationship between beta-blocker use and anthracycline chemotherapy in protecting against TNBC progression, disease recurrence, and mortality. Beta-blockade improved the efficacy of anthracycline chemotherapy in TNBC mouse models by reducing metastatic development. Anthracycline chemotherapy increased sympathetic nerve fiber activity and norepinephrine concentration in mammary tumors, but this effect can be overcome by inhibiting beta 2-adrenergic signaling in the tumor microenvironment.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Multidisciplinary Sciences

SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes

Lakshini Yasaswi Herat, Jennifer Rose Matthews, Moira Hibbs, Elizabeth Piroska Rakoczy, Markus Peter Schlaich, Vance Bruce Matthews

Summary: SGLTs are transport proteins that can be inhibited to improve glycemic control and provide cardiorenal benefits. Dual SGLT1/2 inhibitors, such as sotagliflozin, target both SGLT1 and 2 proteins.

ISCIENCE (2023)

Review Biochemistry & Molecular Biology

The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status

Jennifer Matthews, Lakshini Herat, Markus P. Schlaich, Vance Matthews

Summary: Chronic Kidney Disease (CKD) and Cardiovascular Disease (CVD) can occur together as cardiorenal disease. Sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors show promise in treating cardiorenal disease by improving various indicators through multiple mechanisms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据